Keywords: Bi-specific antibody; BsAb; PLC; PLEVA; disorders; drug reactions; immunomodulation; immunotherapy; lymphoproliferative; multiple myeloma; oncoderm; pathology; pityriasis lichenoides et varioliformis acuta.